Does PROCARBAZINE Cause Malignant neoplasm progression? 96 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 96 reports of Malignant neoplasm progression have been filed in association with PROCARBAZINE (Matulane). This represents 1.5% of all adverse event reports for PROCARBAZINE.
96
Reports of Malignant neoplasm progression with PROCARBAZINE
1.5%
of all PROCARBAZINE reports
38
Deaths
27
Hospitalizations
How Dangerous Is Malignant neoplasm progression From PROCARBAZINE?
Of the 96 reports, 38 (39.6%) resulted in death, 27 (28.1%) required hospitalization, and 3 (3.1%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PROCARBAZINE. However, 96 reports have been filed with the FAERS database.
What Other Side Effects Does PROCARBAZINE Cause?
Nausea (1,029)
Fatigue (890)
Vomiting (375)
Neutropenia (311)
Off label use (301)
Constipation (274)
Platelet count decreased (246)
White blood cell count decreased (229)
Headache (222)
Acute myeloid leukaemia (195)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which PROCARBAZINE Alternatives Have Lower Malignant neoplasm progression Risk?
PROCARBAZINE vs PROCHLORPERAZINE
PROCARBAZINE vs PROCHLORPERAZINE EDISYLATE
PROCARBAZINE vs PROCRIT
PROCARBAZINE vs PROCYCLIDINE
PROCARBAZINE vs PROGESTERONE